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Antimicrobial synergy of cationic grafted
poly(para-phenylene ethynylene) and poly(para-
phenylene vinylene) compounds with UV or metal
ions against Enterococcus faecium
Jordan McBrearty,a David Barker, b Mona Damavandi,b Joels Wilson-Nieuwenhuis,a
Lisa I. Pilkington,b Nina Dempsey-Hibbert,a Anthony J. Slate a
and Kathryn A. Whitehead *a
The rise in multidrug resistant bacteria is an area of growing concern and it is essential to identify new biocidal
agents. Cationic grafted compounds were investigated for their antimicrobial properties using minimum
inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests. Synergy testing was
carried out using the compounds in the presence of ultraviolet (UV). Fractional inhibitory concentration
(FIC) and fractional bactericidal concentration (FBC) tests were carried out using the cationic molecules in
conjunction with metal ion solutions of gold, silver, palladium, platinum, rhodium, titanium, tin, vanadium
and molybdenum. Individually, the cationic compounds containing quaternary amines, polyphenylene
vinylene (PPV) with long polyacrylate grafts (PPV-g-PMETAC (HMw)), polyphenylene ethylene (PPE) with
long polyacrylate grafts (PPE-g-PMETAC (HMw)), polyphenylene vinylene (PPV) with short polyacrylate
grafts (PPV-g-PMETAC (LMw)) and polyphenylene ethylene (PPE) with short polyacrylate grafts (PPE-g-
PMETAC (LMw)) were eﬀective against Enterococcus faecium. The most successful compound under UV
was PPV-g-PMETAC (HMw). Following the FICs, palladium and rhodium ion solutions caused a synergistic
reaction with all four tested compounds. The presence of conjugated bonds in the cationic molecules
increased its antimicrobial activity. These results suggest that the chemical backbone of the compounds,
alongside the chain lengths and chain attachment aﬀect the antimicrobial eﬃcacy of a compound. These
factors should be taken into consideration when formulating new biocidal combinations.
1. Introduction
Antimicrobial resistance (AMR) is a serious worldwide issue, with
our ability to treatmany infections becoming increasingly diﬃcult.
Cationic antimicrobials have been widely deployed in antisepsis
for well over half a century without any apparent reduction in their
eﬀectiveness.1 Cationic compounds have an overall positive
charge, which inuences the interactions between the molecule
and the bacterial cells.2 Conjugated polyelectrolytes (CPEs) have
attracted much attention in recent years as a new class of mate-
rials.3–5 Within the diverse categories of synthesised CPEs,
modied-charge CPEs have been shown to demonstrate antibac-
terial eﬃciency, which has been attributed to their structure.6–9
The antimicrobial ability of compounds can be altered or
improved by the manipulation of specic variables or by using
them in combination with other treatments to yield synergistic
eﬀects. Photo-stimulation can be used to activate some classes of
compounds, resulting in chemical reactions that make the
molecules more biologically active. The utilization of light to
activate or enhance the biocidal activity of compounds generally
results in a process that causes a phototoxic reaction, resulting in
the release of a reactive oxygen species, leading to cell damage or
death.10,11 Metals are known to have antimicrobial properties and
silver is arguably the best known antimicrobial metal, although
its activity varies in diﬀerent forms.12,13 Gold complexes have
historically been investigated as antimicrobial compounds
showing excellent activity against wound and other skin related
infections.14 Palladium, platinum and rhodium are all platinum
group metals which share similar physical and chemical prop-
erties resulting in similar antimicrobial potentials.15,16 Titanium,
tin, gallium and molybdenum have also all been shown to have
antimicrobial potential in various forms.17–19 Vanadium-based
compounds have previously displayed antimicrobial properties
in vanadium peroxidase reactions against Streptococcus mutans
planktonic and biolm morphologies.20
Enterococcus faecium is a commensal bacteria that is usually
a part of the gut micro ora. It is also an opportunistic
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pathogen, oen reported as the causative agent of hospital
acquired infections worldwide.21 E. faecium is one of the top
causes of nosocomial infections and the use of novel biocides to
enable its eﬀective eradication from hospital surfaces and
reduce its transmission would be advantageous. This is espe-
cially important due to the AMR displayed by this particular
bacterial species to a wide range of compounds. The aim of this
proof-of-concept study was to test the antimicrobial eﬃcacy of
modied polymeric polyphenylene ethynylene (PPE) and poly-
phenylene vinylene (PPV) compounds with high and low
molecular weight side chains against E. faecium. The activity of
these compounds in the presence of UV or in conjunction with
metal ion solutions was also tested to look for synergistic
antimicrobial interactions. It was envisaged that such combi-
nations may be advantageous in reducing healthcare related
infections.
2. Material and methods
The compounds used in this study were produced using Acti-
vator ReGenerated by Electron Transfer Atom Transfer Radical
Polymerisation (ARGET ATRP) (Scheme 1).22,23
2.1 Synthetic methods to prepare anti-bacterial polymers
((2,5-Diiodo-1,4-phenylene)bis(oxy))bis(propane-3,1-diyl) bis(2-
bromo-2-methylpropanoate) 1 was prepared as follows. 4-
Dimethylaminopyridine (DMAP) (28 mg, 0.23 mmol) followed
by a-bromoisobutyryl bromide (140 mL, 1.13 mmol) was added
dropwise to a solution of 3,30-((2,5-diiodo-1,4-phenylene)
bis(oxy))bis(propan-1-ol) (200 mg, 0.42 mmol) in dry dime-
thylformamide (DMF) (4 mL) and triethylamine (200 mL) and
was stirred at 0 C, then warmed to room temperature over
48 h.22 The mixture was ltered, washed with water (15 mL),
NH4Cl (15 mL), NaHCO3 (15 mL) and brine (15 mL) then dried
over sodium sulphate. The solvent was removed under vacuum
and the mixture was puried using ash chromatography (n-
hexanes-EtOAc, 9 : 1) to give 1 (0.134 g, 75%) as a white solid.
The spectroscopic data matched that previously reported in
literature.22
2.2 Preparation of copolymer 1-g-PMETAC
The solution mixture of dibromide 1 (15 mg, 0.02 mmol) in
DMSO (5 mL) was added to a solution of [2-(methacryloyloxy)
ethyl]trimethylammonium chloride (METAC) (1.88 mL, 10
mmol) in DMSO (10 mL) and water (0.6 mL) and le at room
temperature until a clear solution was obtained. The ligand–
catalyst complex was prepared by adding N,N,N0,N00,N00-pen-
tamethyldiethylenetriamine (PMDETA) (7.5 mg, 0.041 mmol) to
Cu(II)Cl (2 mg, 0.0148 mmol) in anisole (1 mL) at 67 C. The
ligand–catalyst complex was added to the reaction mixture and
heated to 60 C. A mixture in anisole (1 mL) of ascorbic acid
(980 mg, 5.56 mmol) and water (0.30 mL) was added slowly to
the reaction and le under an atmosphere of nitrogen at 60 C
for 24 h. The reaction was quenched with exposure to air and by
cooling the reaction ask in liquid nitrogen. The precipitated
graed polymer was ltered and dissolved in water (5 mL). The
graed polymer was re-precipitated into acetone (100 mL) and
centrifuged to collect the product as a white solid (78 mg, 42%).
dH (300 MHz; D2O): 4.35–4.52 (2H, m, CH2); 3.70–3.77 (2H, m,
CH2); 3.22 (9H, s, CH3); 1.95–2.02 (1H, m, CH); 1.31–1.55 (2H,
m, CH2). GPC: Mw: 6.41  103, Mn: 4.98  103, Mw/Mn: 1.29.
2.3 Preparation of copolymers PPV-g-PMETAC (HMw) and
PPV-g-PMETAC (LMw) from PPVMI
A solution of PPVMI (270 mg, 0.01 mmol) in DMSO (5 mL) was
added to a stirring solution of METAC (1.88 mL, 10 mmol) in
DMSO (5 mL) and water (600 mL) to achieve a colourless solu-
tion.23 Separately the ligand–catalyst complex was prepared by
adding PMDETA (7.5 mg, 0.041 mmol) into a mixture of Cu(II)Cl
(2 mg, 0.0148 mmol) mixture in anisole (1 mL) at 67 C for 3 h.
This complex was added to the reaction mixture at 60 C. A
solution of ascorbic acid (980 mg, 5.56 mmol) in anisole (1 mL)
and water (300 mL) was added slowly to the reaction and le for
24 h under an atmosphere of nitrogen at 60 C. The reaction was
quenched by cooling the mixture with liquid nitrogen and then
exposing the mixture to air. The orange precipitate was
collected and dissolved in water, then was re-precipitated using
acetone (100 mL) and collected using centrifugation to produce
a bright orange solid PPV-g-PMETAC (HMw) (850 mg, 55%). dH
(400 MHz; D2O): 1.01–1.10 (2H, m, CH2), 1.95–2.01 (1H, m, CH),
3.25 (9H, br s, CH3), 3.75–3.82 (2H, m, CH2), 4.45–4.50 (2H, m,
CH2). GPC: Mw: 77.50  103, Mn: 46.19  103, Mw/Mn: 1.68. lmax
abs ¼ 435 nm. lmax em ¼ 535 nm. The same procedure was used
to achieve the low molecular weight polymer, except diﬀerent
amounts of the chemicals were used; METAC (950 mL, 5 mmol)
in DMSO (5 mL) and water (300 mL) with ascorbic acid (600 mg,
3.40 mmol) in anisole (1 mL) and water (150 mL) to give a bright
orange solid PPV-g-PMETAC (LMw) (180 mg, 40%). dH (400
MHz; D2O): 1.01–1.10 (2H, m, CH2), 1.92–2.03 (1H, m, CH), 3.28
(9H, br s, CH3), 3.77–3.85 (2H, m, CH2), 4.43–4.48 (2H, m, CH2).
GPC: Mw: 22.87  103, Mn: 16.72  103, Mw/Mn: 1.37. lmax abs ¼
435 nm. lmax em ¼ 537 nm (Fig. 1).
2.4 Preparation of copolymers PPE-g-PMETAC (HMw) and
PPE-g-PMETAC (LMw) from PPEMI
A solution of PPEMI (220 mg, 0.02 mmol) in DMSO (5 mL) was
added to a stirring solution of DMSO (5 mL) and water (600 mL)
containing METAC (1.88 mL, 10 mmol) to achieve a colourless
solution.23 Separately, the ligand–catalyst complex was prepared
by adding PMDETA (7.5 mg, 0.041 mmol) into amixture of Cu(II)
Cl (2 mg, 0.0148 mmol) in anisole (1 mL) for 3 h at 67 C. This
complex was added to the reaction mixture at 60 C. A solution
of ascorbic acid (980 mg, 5.56 mmol) in anisole (1 mL) and
water (300 mL) was added slowly to the reaction and le at 60 C
for 24 h under an atmosphere of nitrogen. The reaction was
quenched by cooling the mixture with liquid nitrogen and
exposing the mixture to air. The orange precipitate was
collected and then dissolved in water, then was re-precipitated
using acetone (100 mL) and collected using centrifuge to ach-
ieve a bright orange solid PPE-g-PMETAC (HMw) (870 mg, 63%).
dH (400 MHz; D2O): 1.02–1.11 (2H, m, CH2), 1.97–2.03 (1H, m,
CH), 3.26 (9H, br s, CH3), 3.77–3.82 (2H, m, CH2), 4.47–4.51 (2H,
23434 | RSC Adv., 2018, 8, 23433–23441 This journal is © The Royal Society of Chemistry 2018
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m, CH2). GPC: Mw: 77.48  103, Mn: 46.03  103, Mw/Mn: 1.68.
lmax abs ¼ 428 nm. lmax em ¼ 493 nm. The same procedure was
used to achieve the low molecular weight polymer, except using
METAC (950 mL, 5 mmol) in DMSO (5 mL) and water (300 mL)
and a solution of ascorbic acid (600mg, 3.40mmol) in anisole (1
mL) and water (150 mL) to give a bright orange solid PPE-g-
PMETAC (LMw) (190 mg, 43%). dH (400 MHz; D2O): 1.04–1.13
(2H, m, CH2), 1.95–2.01 (1H, m, CH), 3.24 (9H, br s, CH3), 3.78–
3.83 (2H, m, CH2), 4.45–4.47 (2H, m, CH2). GPC: Mw: 21.97 
103, Mn: 16.20  103, Mw/Mn: 1.36. lmax abs ¼ 428 nm. lmax em ¼
497 nm.
For use in the assays, polyphenylene vinylene (PPV) and
polyphenylene ethynylene (PPE) polymers were suspended in
undiluted water, except for the ungraed PPV and PPE which
were suspended in undiluted DMSO. The composition of the
compounds is described (Table 1).
Scheme 1 Synthesis of PPV-g-PMETAC, PPE-g-PMETAC and 1-g-PMETAC.
This journal is © The Royal Society of Chemistry 2018 RSC Adv., 2018, 8, 23433–23441 | 23435
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2.5 Cultures and media
Stock cultures of E. faecium NCTC 7171 were sub-cultured onto
columbia blood agar (Oxoid, UK) with debrillated horse blood
(TCS Biosciences Ltd, UK). Bacterial cultures were grown in
a 5% CO2 incubator for 24 h at 37 C. Brain heart infusion
(BHIA) agar (Oxoid, UK) and brain heart infusion broth (BHIB)
(Oxoid, UK) were used for all the microbiological tests.
2.6 Bacterial preparation
A single colony of E. faecium was inoculated from a BHIA plate
into 10 mL of BHIB. The inoculated culture was incubated in
a 5% CO2 incubator without shaking for 24 h. Cells were har-
vested by centrifugation (567g for 10 min) and then washed with
10 mL sterile distilled water (dH2O) and vortexed. The washed
cells were re-centrifuged and the pellet was re-suspended in
10 mL of dH2O, vortexed and the resultant cell suspension was
adjusted to an optical density (OD) at 540 nanometres (nm)
(OD540) of 1.0 (0.05) using a spectrophotometer. The cell
concentration corresponded to 3.95  108 colony-forming units
per mL (CFU mL1) at an OD540 of 1.0.
2.7 Minimal inhibitory concentrations (MIC) and minimal
bactericidal concentrations (MBC) assays
A culture of E. faecium was prepared and triphenyl tetrazolium
chloride (TTC) (Sigma-Aldrich, UK) was added to obtain
a working concentration 0.15 w/v. To a 96 well at-bottomed
micro titre plate, 100 mL of antimicrobial sample was added
to the appropriate row/column. One-hundred micro litres of the
bacterial suspension with the TTC was added to the wells to be
tested. Using a multi-channel pipette the rst column was
mixed, then 100 mL of the sample/bacterial mix was transferred
to the next column and mixed until completion until the nal
column whereby 100 mL was discarded. One-hundred micro
litres of the bacterial suspension without the test sample was
used as a positive control and 100 mL of sterile double strength
broth was used as a negative control. Micro titre plates were
incubated in a 5% CO₂ incubator at 37 C for 24 h. Aer incu-
bation, the MIC was taken as the lowest concentration that
inhibited the visible growth of the bacteria by comparison with
the controls (wells turned dark blue/purple indicating growth).
The MBC was determined by removing 25 mL of culture from
each well that showed no growth. This was pipetted onto agar
Fig. 1 UV-Vis absorption spectra of PPV-g-PMETAC (LMw, light grey) and PPE-g-PMETAC (dark grey).
Table 1 Descriptions of the compounds used in this study
Class Number Structure
Cationic compounds 1-g-PMETAC Non-conjugated polymer (NCP) side chains
(quaternary amine acrylic (cationic)) were
graed, not conjugated
PPV-g-PMETAC (HMw) Polyphenylene vinylene (PPV) with long
polyacrylate gras containing quaternary
amines
PPE-g-PMETAC (HMw) Polyphenylene ethylene (PPE) with long
polyacrylate gras containing quaternary
amines
PPV-g-PMETAC (LMw) Polyphenylene vinylene (PPV) with short
polyacrylate gras containing quaternary
amines
PPE-g-PMETAC (LMw) Polyphenylene ethylene (PPE) with short
polyacrylate gras containing quaternary
amines
Neutral compounds p-Phenylene vinylene PPV: ungraed polyphenylene vinylene
p-Phenylene ethylene PPE: ungraed polyphenylene ethylene
23436 | RSC Adv., 2018, 8, 23433–23441 This journal is © The Royal Society of Chemistry 2018
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and incubated in a 5% CO₂ incubator at 37 C for 24 h. The
colonies were counted and calculated to give the CFU mL1.
Aer incubation, the lowest concentration well sample that
showed no bacterial growth on the agar plate was determined to
be the MBC for that test sample (n ¼ 3).
2.8 UV MIC and MBC assays
MIC and MBC tests were performed aer incubation of the test
compounds under UV (UVP Blak-ray, US 365 nm wavelength) at
3 time points, 30 min, 60 min and 90 min (n ¼ 3).
2.9 Fractional inhibitory (FIC) and fractional bactericidal
concentration (FBC) assays
The MICs of the metal ion solution synergies were determined
using FIC antimicrobial screening. The metal ion solutions
were obtained from Sigma, (UK). The bacterial suspension and
test samples for the FIC test were prepared as described in the
section bacterial preparation and MIC method, except that the
compound and metal ion solutions were added to the wells in
a 1 : 1 ratio (n ¼ 3). The prepared solutions were homogeneous
with no apparent aggregates formed. The same method was
carried out for the FBCs except that the bactericidal concen-
trations were used.
Following incubation at 37 C for 24 h, the FIC values were
calculated as;
X
FIC ¼ FIC of antimicrobial A
þ FIC of antimicrobial B
¼ MIC of antimicrobial A in combination
MIC of antimicrobial A alone
þMIC of antimicrobial B in combination
MIC of antimicrobial B alone
(1)
Depending on the FIC values, the antimicrobial interaction
was evaluated as synergy ¼ #0.5, additive ¼ >0.5 # 1.0, indif-
ference ¼ <1.0 # 4.0 or antagonism ¼ >4.0.
2.10 Statistical analysis
Mean values were used to compare the antimicrobial eﬃcacy
results. Standard errors were calculated to analyse the distri-
butions of the data from the mean value, and condence
intervals of 95% were calculated to compare the signicance of
the results.
3. Results
3.1 MIC of novel compounds with and without UV
When the compounds were tested against E. faecium, it was
demonstrated that all the graed poly(para-phenylene ethyny-
lene) (PPE) or poly(para-phenylene vinylene) (PPV) compounds
demonstrated greater antimicrobial activity compared to the
ungraed PPE (1250 mg mL1) or PPV (1250 mg mL1) alone
(Table 2). The non-conjugated cationic polymer, 1-g-PMETAC,
demonstrated the least antimicrobial activity at 2500 mg mL1,
suggesting that, against E. faecium, the presence of conjugated
bonds in the molecule increased its antimicrobial activity. Of
the conjugated molecules, PPV-g-PMETAC (HMw) demon-
strated the best antimicrobial activity (65.1 mg mL1), whilst
PPE-g-PMETAC (HMw), PPV-g-PMETAC (LMw) and PPE-g-PME-
TAC (LMw) demonstrated inhibitory eﬀects at 104.2 mg mL1
(Table 2).
To determine whether any of the compounds were poten-
tially UV activated, MICs were repeated with 30 min, 60 min and
90 min exposure to UV prior to testing (Table 2). Aer 30 min of
UV exposure all the compounds demonstrated an increase in
antimicrobial eﬃcacy, with PPV-g-PMETAC (HMw) once again
being the most active (39.1 mg mL1). The PPE-g-PMETAC
(HMw), PPV-g-PMETAC (LMw) and PPE-g-PMETAC (LMw) all
demonstrated improved activity compared to the control with
MICs at 78.1 mg mL1. Aer 60 min of UV exposure, the lowered
MIC results were the same as those demonstrated following
30 min of UV, with the exception of the PPV-g-PMETAC (LMw),
which required a higher concentration to inhibit growth (156.3
mg mL1). Aer 90 min of UV exposure, only the PPE-g-PMETAC
(LMw) demonstrated an MIC better than the control (78.1 mg
mL1). Overall, the cationic molecules with the longest side
chains, PPV-g-PMETAC (HMw) and PPE-g-PMETAC (HMw),
demonstrated greater antimicrobial activity than the cationic
molecules with the shorter side chains in the presence of UV.
Throughout the work, the ungraed PPE and PPV did not
demonstrate any enhancement by UV, whilst the 1-g-PMETAC
required a greater concentration following 90 min UV irradia-
tion from 2500 mg mL1 to 5000 mg mL1 (Table 2).
3.2 MBC of novel compounds (with and without UV
radiation)
Similarly to the MIC results, the MBC results demonstrated that
PPV-g-PMETAC (HMw) had the greatest bactericidal potential
(625 mg mL1), followed by PPE-g-PMETAC (HMw) (833.3 mg
Table 2 MIC (mg mL1) of the novel cationic compounds before and after being incubated under UV for 30 min, 60 min and 90 min. MIC
indicates the lowest concentrations where inhibition eﬀects were observed
UV duration 1-g-PMETAC
PPV-g-PMETAC
(HMw)
PPE-g-PMETAC
(HMw)
PPV-g-PMETAC
(LMw)
PPE-g-PMETAC
(LMw)
Ungraed
PPV
Ungraed
PPE DMSO
0 min 2500 65.1 104.2 104.2 104.2 1250 1250 1250
30 min 2500 39.1 78.1 78.1 78.1 1250 1250 1250
60 min 2500 39.1 78.1 156.3 78.1 1250 1250 1250
90 min 5000 78.1 156.3 156.3 78.1 1250 1250 1250
This journal is © The Royal Society of Chemistry 2018 RSC Adv., 2018, 8, 23433–23441 | 23437
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mL1) (Table 3). Both PPV-g-PMETAC (LMw) and PPE-g-PME-
TAC (LMw) also demonstrated bactericidal potential (1250 mg
mL1), but were less eﬀective. None of the remaining
compounds, 1-g-PMETAC, the ungraed PPV and PPE or the
DMSO demonstrated any bactericidal properties, even when
exposed to UV treatment. In contrast, PPV-g-PMETAC (HMw)
demonstrated an increase in bactericidal properties (312.5 mg
mL1) aer 30 and 60 min UV and a further increase aer
90 min (156.3 mg mL1) (Table 3). However, PPE-g-PMETAC
(HMw), PPV-g-PMETAC (LMw) and PPE-g-PMETAC (LMw)
demonstrated a reduction or no change in their bactericidal
properties aer 30 or 60 min UV exposure. Only aer 90 min did
PPE-g-PMETAC (HMw) and PPE-g-PMETAC (LMw) demonstrate
an increase in bactericidal properties (625 mg mL1) (Table 3).
Taken together, HMW conjugated compounds had the greatest
bactericidal potential on their own and in the presence of UV,
and UV was shown to increase the antimicrobial eﬃcacy of PPV-
g-PMETAC (HMw) in the short term.
3.3 MIC and MBC of metal ion solutions
To identify metal ion solutions which may improve the anti-
microbial ability of the novel compounds, the MIC and MBC of
selected metal ion solutions was investigated (Table 4). The
most eﬀective metal ion solutions at inhibiting E. faecium
growth were gold, tin and molybdenum (15.63 mg mL1), whilst
palladium, platinum, rhodium, silver and vanadium were also
eﬀective (31.25 mg mL1). Metal ion solutions that demon-
strated lower inhibitory activity included titanium (62.5 mg
mL1), rhenium (78.13 mg mL1), and chromium (125 mg mL1).
Nickel, yttrium, copper, bismuth and scandium ion solutions
did not display any inhibitory eﬀects (Table 4).
In addition to displaying the lowest MIC, tin and molyb-
denum had the greatest bactericidal properties (31.25 mg mL1),
whilst gold, palladium, platinum and rhodium ion solutions
(62.5 mg mL1) also demonstrated positive MBC results.
Rhenium and copper ion solutions (250 mgmL1) demonstrated
weaker bactericidal eﬀects, whilst silver, titanium, yttrium,
nickel, chromium, vanadium, gallium, bismuth, and scandium
ion solutions showed no activity (Table 4).
3.4 FIC synergy of the metals and novel compounds
Aer identifying the most eﬀective metal ion solutions and
compounds, the most inhibitory metal ion solutions, gold tin,
molybdenum, silver, palladium, platinum, rhodium, vanadium
and titanium were investigated in combination with the four
main cationic compounds to determine a possible synergistic
relationship between them. None of the combinations caused
any antagonistic responses, with all the responses being either
additive or synergistic, with the exception of PPE-g-PMETAC
(LMw) and vanadium ion solution which was indiﬀerent (Table
5). Many of the combinations caused synergistic responses, but
only palladium and rhodium ion solutions caused a synergistic
reaction with all four compounds. The platinum ion solution
was also synergistic and had a positive reaction with three of the
compounds excluding PPV-g-PMETAC (HMw). Both tin and
molybdenum ion solutions, which demonstrated the best MIC
and MBC results, had a synergistic reaction with both of the
PPV-based compounds and demonstrated additivity with the
PPE-based compounds. Finally, the remaining metal ion solu-
tions, gold, silver, titanium and vanadium all demonstrated
synergistic reactions with one of the PPV-based compounds and
were additive with all the others (Table 5).
3.5 FBC synergy of the metals and novel compounds
Similarly, to the FIC, the most bactericidal metal ion solutions
and compounds were tested at their bactericidal concentrations
in combination to determine any synergy in their bactericidal
properties. None of the combinations demonstrated any
synergistic eﬀects, however, gold, palladium, platinum,
rhodium, and vanadium ion solutions all demonstrated addi-
tive responses with PPV-g-PMETAC (HMw). All other
Table 4 MIC and MBC (mg mL1) for metal ion solutions against E.
faecium
Metal ion MIC (mg mL1) MBC (mg mL1)
Gold 15.63 62.5
Tin 15.63 31.25
Molybdenum 15.63 31.25
Silver 31.25 250
Palladium 31.25 62.5
Platinum 31.25 62.5
Rhodium 31.25 62.5
Bismuth 46.88 125
Vanadium 46.88 187.5
Gallium 62.5 125
Titanium 62.5 250
Ruthenium 62.5 125
Rhenium 78.13 125
Copper 125 62.5
Yttrium 125 250
Nickel 125 250
Chromium 125 250
Scandium 125 125
Table 3 MBC (mg mL1) of the novel cationic compounds before and after being incubated under UV for 30 min, 60 min and 90 min. MBC
indicated the lowest concentrations bactericidal eﬀects were observed
UV duration 1-g-PMETAC
PPV-g-PMETAC
(HMw)
PPE-g-PMETAC
(HMw)
PPV-g-PMETAC
(LMw)
PPE-g-PMETAC
(LMw)
Ungraed
PPV
Ungraed
PPE DMSO
0 min 0 625 833.3 1250 1250 0 0 0
30 min 0 312.5 1250 1250 1250 0 0 0
60 min 0 312.5 1250 1250 1250 0 0 0
90 min 0 156.3 625 2500 625 0 0 0
23438 | RSC Adv., 2018, 8, 23433–23441 This journal is © The Royal Society of Chemistry 2018
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combinations resulted in an indiﬀerent or an antagonistic
reaction when in combination with the compounds (Table 6).
4. Discussion
All of the conjugated cationic compounds, PPV-g-PMETAC
(HMw), PPE-g-PMETAC (HMw), PPV-g-PMETAC (LMw) and PPE-
g-PMETAC (LMw), demonstrated positive inhibitory and bacte-
ricidal properties when tested alone. The eﬀects demonstrated
were greater than those of the ungraed PPV and PPE, indi-
cating that this eﬀect was due to the side chains present on the
four cationic compounds. The non-conjugated compound, 1-g-
PMETAC, demonstrated the least inhibitory eﬀects and no
bactericidal eﬀect; for antimicrobial activity to be observed,
bottle-brush type conjugated polymers were necessary; this
observation is likely due to the high spatial density of cationic
ammonium groups as the spatial density of the aforementioned
cationic groups was signicantly higher in the case of PPV/PPE-
g-PMETAC (with brush architecture) as opposed to 1-g-PME-
TAC. Sambhy et al. (2008) demonstrated that an increase in
spatial density by varying spatial positioning and charge/tail
ratios of homologous amphiphilic pyridinium polymers
signicantly increased bacterial membrane-disrupting activi-
ties as evidenced via antibacterial and hemolytic assays.24 This
suggested that graing instead of conjugating the side chains
had an impact on its antimicrobial abilities. It has been sug-
gested that the type of binding of the side chains in cationic
compounds inuences the bioactivity, due to the electrostatic
interactions between the compound and the bacterial cell, since
cationic surfactants have been found to cause the disintegration
of the cell surface of Escherichia coli.25 Further, under UV
conditions, the cationic molecules with the longer side chains
demonstrated increased antimicrobial activity than those with
the shorter side chains. Similar results have been demonstrated
whereby cationic amino acids showed an increased aﬀectivity in
longer chain length acids against Gram-positive bacteria.26 The
eﬀect of polymer conformation, in regards to molecular rigidity,
must also be considered. The conjugated polymer backbones
utilized throughout this study were expected to enhance the
molecular rigidity, and therefore contribute towards the
demonstrated antimicrobial eﬃcacy. It has previously been
demonstrated that the utilisation of more rigid peruoroalkyl
side chains signicantly improved antimicrobial eﬃcacy when
compared against a more exible alkyl side chain.27
Similar eﬀects have been noted in the UV activation of
riboavin and its antimicrobial properties against bacteria
related to keratitis infections, whereby the results showed there
was a signicant increase in activity when doubling the UV
radiation.28 Previous research into the investigation and
improvement of antimicrobials has indicated some success
with light manipulation.10,29 Corbitt et al. (2008) developed
conjugated polyelectrode capsules produced by layering poly-
cations and polyanions onto a MnCO3 template, essentially
creating a molecule, which acted as a trap to contain bacteria.
When incubated under visible light, this resulted in bacterial
cell death, and proved eﬀective against Gram-negative Pseudo-
monas aeruginosa.4 In the present study, it is suggested that
photo-activation (via UV) of the conjugated polymer backbone
may have resulted in alternative antimicrobial mechanisms.30,31
When utilized alongside the primary antimicrobial mechanism
of charged cationic activity, the use of UV may have resulted in
an enhanced antimicrobial eﬃcacy. Further, in a study con-
ducted by Wang et al. (2013), it was revealed that upon UV light
exposure, Gram-negative bacteria (in this case Escherichia coli)
sustained both cell membrane and cytoplasm damage, whilst
Gram-positive bacteria (Staphylococcus epidermidis) demon-
strated damages to the cell envelope.31 It has previously been
demonstrated that UV exposure of CPEs can be correlated with
the generation of singlet oxygen species (1O2) and therefore
subsequent production of secondary reactive oxygen species
(ROS).3,32 These results suggested that the way the UV interacts
with the compounds may improve the antimicrobial inhibitory
ability of certain compound structures. In the cases where
a higher MIC value was recorded following a period of UV light
incubation, it can be suggested that there was possible degra-
dation of the functional groups present on the cationic poly-
mers which would lead to a reduction in antimicrobial activity.
Table 6 FBC (mg mL1) of the activity between the novel compounds and metal ion solutions
Au Sn Mo Ag Pd Pt Rh V Ti
PPV-g-PMETAC (HMw) 1.00 6.00 6.00 1.25 1.00 1.00 1.00 1.00 1.25
PPE-g-PMETAC (HMw) 1.17 6.33 6.33 1.33 1.17 1.17 1.17 1.08 1.78
PPV-g-PMETAC (LMw) 1.50 7.00 7.00 1.50 1.50 1.50 1.50 0.83 1.50
PPE-g-PMETAC (LMw) 1.50 3.00 7.00 2.00 1.50 1.50 1.50 1.25 1.50
Table 5 FIC of the activity between the novel compounds and metals tested against E. faecium. FIC was calculated using the equation set out in
the materials and methods section
Au Sn Mo Ag Pd Pt Rh V Ti
PPV-g-PMETAC (HMw) 0.71 0.26 0.26 0.47 0.31 0.60 0.31 0.39 0.41
PPE-g-PMETAC (HMw) 0.54 0.54 0.54 0.64 0.43 0.43 0.43 0.74 0.84
PPV-g-PMETAC (LMw) 0.38 0.38 0.38 0.64 0.43 0.39 0.39 0.92 0.56
PPE-g-PMETAC (LMw) 0.54 0.54 0.54 0.64 0.43 0.43 0.43 1.60 0.84
This journal is © The Royal Society of Chemistry 2018 RSC Adv., 2018, 8, 23433–23441 | 23439
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Future studies will be conducted in order to oﬀer a more thor-
ough understanding to this phenomenon. It agreement with
our work, it was recently it was demonstrated that manganese-
based photoactivatable antibacterial compounds were not
necessarily more eﬀective upon UV exposure.33
The initial MIC and MBC assays of the metals demonstrated
that the most antimicrobial ion solutions against E. faecium
were gold, silver, palladium, platinum, rhodium, titanium, tin,
vanadium and molybdenum. Inhibition by silver was expected
as silver ion solution has previously been identied as an
eﬀective bacterial inhibitor and has been utilized in many
coatings and topical medications, but lacked bactericidal
properties when used in ionic form in our study.
When tested for any synergistic inhibitory interactions (FIC),
there were a number of positive synergistic reactions between
the metal ion solutions and compounds. Any reactions that
were not synergistic only additive with the exception of the PPE-
g-PMETAC (LMw) and the vanadium ion solution which
demonstrated an indiﬀerent combination. Overall, PPV-g-
PMETAC (HMw) was the most synergistic, showing synergy with
seven of the nine metal ion solutions tested, closely followed by
PPV-g-PMETAC (LMw) which demonstrated synergy with six of
the nine metal ion solutions. From this, it appeared that the two
PPV-based compounds exhibited better synergistic eﬀects than
the two PPE-based compounds, PPE-g-PMETAC (HMw) and
PPE-g-PMETAC (LMw), which both only demonstrated synergy
with three of the nine metal ion solutions. This might be sug-
gested to be due to the chemical diﬀerences in the compound
backbone, enhancing the antibacterial eﬃcacy if the
compounds. As for the metal ion solutions, the best two were
palladium and rhodium, which demonstrated synergy with all
the compounds, whilst the metal ion solutions that showed the
best inhibitory eﬀects when alone, gold, tin and molybdenum,
were only synergistic with a single compound.
When synergy was tested for the metal ion solutions and
compounds for their bactericidal eﬀects (FBC), none of the
combinations produced any synergistic eﬀects, with most
combinations being indiﬀerent. The least two FBC metal ion
solutions were tin and molybdenum, which demonstrated
antagonistic eﬀects, despite them demonstrating positive
results when used alone. Gold, tin and molybdenum ion solu-
tions demonstrated the best inhibitory and bactericidal eﬀects
when used alone in this study. Gold has been previously shown
to have inhibitory potential in the form of nanoparticles.34 The
addition of tin complexes to thiosemicarbazones has been
shown to improve the compounds overall eﬃcacy;35 prior
studies with non-cytotoxic molybdenum disulde nano-
structures have also yielded positive results.36 Other metals that
demonstrated some activity in our study have also been previ-
ously shown to demonstrate antimicrobial activity. Vanadium
based compounds have previously displayed antimicrobial
properties in vanadium peroxidase reactions with Streptococcus
mutans in planktonic and biolm form.20 Palladium and plat-
inum alloys have also been considered as potential antimicro-
bial materials for use as medical implants, such as
cardiovascular debrillators or hip and knee implants and
catheters.37,38 Rhodium complexes with tetraaza macrocyclic
and heterocyclic nitrogen ligands have shown eﬀective antimi-
crobial eﬃcacy against Escherichia coli and Staphylococcus
aureus, particularly against Gram-positive bacteria.39 Finally,
surface modications using titanium has been demonstrated to
have an antimicrobial eﬀect on Porphyromonas gingivalis and
Actinobacillus actinomycetemcomitans.40
5. Conclusion
The use of the conjugated bonds in the formation of the
cationic molecules increased antimicrobial activity. High
Molecular weight (HMW) conjugated compounds had the
greatest bactericidal potential on their own and in the presence
of UV, which increased the antimicrobial eﬃcacy of some HMW
compounds in the short term. The most inhibitory/bactericidal
metals were gold, silver, palladium, platinum, rhodium, tita-
nium, tin, vanadium and molybdenum. Following the frac-
tional inhibitory concentrations (FIC)s, palladium and rhodium
caused a synergistic reaction with all four compounds whilst all
the other metal-compounds demonstrated additive reactions
with the exception of PPE-g-PMETAC (LMw) and vanadium.
Using synergy with the bactericidal concentrations (FBC)s, gold,
palladium, platinum, rhodium, and vanadium all demon-
strated additive responses with PPV-g-PMETAC (HMw). The two
PPV-based compounds exhibited better synergistic eﬀects with
the metals tested. These results suggest that even when using
very similar chemical moieties, the chemical backbone of
compounds, alongside the chain lengths and the means of
chain attachment all aﬀect the antimicrobial eﬃcacy of
a compound. Finally, the importance of the positive results
against a potentially AMR organism, E. faecium, is signicant
due to the increase in the incidence of AMR organisms.
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